Oruka
Medical Science Liaison-Southeast
Remote. Posted 6 months ago
The role
The Medical Science Liaison will build and execute a territory engagement plan to establish relationships with external stakeholders and support medical strategy. This field-based role serves as a scientific expert and conduit of communication between the clinical community and the internal team.
What you will do
- Identify, develop, and maintain collaborative relationships with key opinion leaders, speakers and investigators
- Stay informed of medical and scientific developments in Dermatology and related fields
- Support national and regional scientific congresses with KOL engagements, poster/abstract coverage, booth staffing, and company debriefs
- Provide internal stakeholders with feedback and actionable insights from interactions with HCPs
- Identify, engage, and support investigators and site staff of clinical research sites
Required qualifications
- Advanced degree in life sciences (PharmD, PhD, MD/DO, MSN, NP/DNP, DMS/PA or equivalent)
- Minimum of 5 years relevant clinical and/or industry experience
- Prior experience as a field medical science liaison
- Relevant therapeutic area knowledge
- Comprehensive understanding of drug development process, clinical trial design, safety monitoring, and regulatory landscape
- Self-driven and ability to work independently with minimal direct supervision
- Exceptional communication and time management skills
- Must live within applicable territory with convenient access to national/international airport
Nice to have
- Experience in Dermatology
- Routine and tangible experience in a field medical role working with CRO and clinical operations
Benefits
- Competitive salary and benefits package
- Vibrant startup culture
- Supportive and inclusive team environment
- Opportunities for professional growth and development
About the company
Oruka Therapeutics (Nasdaq: ORKA) is developing novel biologics designed to set a new standard for the treatment of chronic skin diseases. The company is advancing a proprietary portfolio of antibodies targeting plaque psoriasis and other dermatologic and inflammatory diseases.